A teacher with a life-threatening heart rhythm disorder is helping to develop high-tech clothing which recognises abnormal ECG patterns. A smart T-shirt with the power of AI could in future detect heart conditions as people go about their daily lives, thanks to research awarded more than...

What are next year’s big trends? Simon Middleton, Head, Europe Life Sciences and Partner at L.E.K. Consulting, shares his predictions. The biopharma industry is at an inflection point going into 2026. Discoveries from the past year will be scaled, particularly...

Insmed recently opened a new R&D facility in Cambridge focused on synthetic rescue for serious diseases. Dr Tom Heightman, SVP of Research at the global biopharmaceutical, explains why the company is focused on UK expansion. Insmed specialises in striving to...

The UK can build on the strong foundations it has already laid to attract the best talent and drive the next generation of scientific discovery, says Rafael Carazo Salas, CEO and founder of CellVoyant. This year we have witnessed a...

Ivan Wall is Professor of Regenerative Medicine at the University of Birmingham and co-director of Resilience - the UK’s Medicines Manufacturing Skills Centre of Excellence. Handling charge Advanced medicines manufacturing is suffering from an acute skills gap, and not enough young...

Researchers at Oxford techbio Etcembly hope to find new targets for cancer therapies by analysing the immune cells of cancer survivors, as principal scientist Mathew Jones explains. Despite all the advances in medicine over the past few decades, curing cancer...

UK-wide genetic testing will boost health, save lives, and create a new pathway for economic innovation, says Dr Stuart J. Grice, co-founder and CSO at FitnessGenes. The United Kingdom is at the forefront of genomics research. Initiatives like the UK...

Partnerships between small biotechs and Big Pharma could unlock faster drug development for rare diseases, says Dan Williams, PhD, CEO of SynaptixBio. In an increasingly interconnected and competitive world, collaboration has become an essential tool for organisations of all sizes....

Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy. Tell us about Isogenica’s work Isogenica are...

Eric Fua, Conference Producer, IMAPAC UK, investigates the challenges and opportunities facing the biomanufacturing industry. Last year, the global biomanufacturing market surged to an astounding US$19.02 billion, signifying the sector’s potential to revolutionise global health.1 Biopharmaceutical manufacturing (or biomanufacturing) is today...

Breast cancer patients could be spared unnecessary chemotherapy thanks to a new gene test. Karen Southern chats to surgical oncologist, Prof Simon Holt, about how genomic breakthroughs like Oncotype DX are transforming UK cancer care. As of 2019, the UK...

Is the UK prepared for a potential bird flu epidemic among humans? The answer is no, says influenza virologist and lecturer, Dr Nicole Robb. The odds of a bird - or avian - flu outbreak in people are low, with...

Synthace is a biotech start-up accelerating biological discovery and optimisation through computer-aided biology. CEO Guy Levy-Yurista tells Bioscience Today why this is the decade when life sciences’ biggest challenges will be solved - in a matter of days. If you...

Shark molecules provide the basis of unique new therapeutics which could transform the treatment of inflammatory diseases and cancer. Karen Southern talks to Dr Caroline Barelle, CEO and founder of Elasmogen, the small biopharmaceutical company behind this potentially huge...

Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses to infection. The coronavirus (COVID-19) pandemic,...